165 related articles for article (PubMed ID: 20181689)
1. Effect of the internal promoter on insertional gene activation by lentiviral vectors with an intact HIV long terminal repeat.
Knight S; Bokhoven M; Collins M; Takeuchi Y
J Virol; 2010 May; 84(9):4856-9. PubMed ID: 20181689
[TBL] [Abstract][Full Text] [Related]
2. Transcriptional targeting of lentiviral vectors by long terminal repeat enhancer replacement.
Lotti F; Menguzzato E; Rossi C; Naldini L; Ailles L; Mavilio F; Ferrari G
J Virol; 2002 Apr; 76(8):3996-4007. PubMed ID: 11907239
[TBL] [Abstract][Full Text] [Related]
3. Integrated self-inactivating lentiviral vectors produce full-length genomic transcripts competent for encapsidation and integration.
Logan AC; Haas DL; Kafri T; Kohn DB
J Virol; 2004 Aug; 78(16):8421-36. PubMed ID: 15280451
[TBL] [Abstract][Full Text] [Related]
4. Insertional gene activation by lentiviral and gammaretroviral vectors.
Bokhoven M; Stephen SL; Knight S; Gevers EF; Robinson IC; Takeuchi Y; Collins MK
J Virol; 2009 Jan; 83(1):283-94. PubMed ID: 18945765
[TBL] [Abstract][Full Text] [Related]
5. Hybrid HIV/MSCV LTR enhances transgene expression of lentiviral vectors in human CD34(+) hematopoietic cells.
Choi JK; Hoang N; Vilardi AM; Conrad P; Emerson SG; Gewirtz AM
Stem Cells; 2001; 19(3):236-46. PubMed ID: 11359949
[TBL] [Abstract][Full Text] [Related]
6. Rev-dependent lentiviral expression vector.
Wu Y; Beddall MH; Marsh JW
Retrovirology; 2007 Feb; 4():12. PubMed ID: 17286866
[TBL] [Abstract][Full Text] [Related]
7. Transgene expression in the mouse cerebellar Purkinje cells with a minimal level of integration using long terminal repeat-modified lentiviral vectors.
Takayama K; Torashima T
J Neurovirol; 2009 Sep; 15(5-6):371-9. PubMed ID: 19739019
[TBL] [Abstract][Full Text] [Related]
8. Foamy Virus Vector Carries a Strong Insulator in Its Long Terminal Repeat Which Reduces Its Genotoxic Potential.
Goodman MA; Arumugam P; Pillis DM; Loberg A; Nasimuzzaman M; Lynn D; van der Loo JCM; Dexheimer PJ; Keddache M; Bauer TR; Hickstein DD; Russell DW; Malik P
J Virol; 2018 Jan; 92(1):. PubMed ID: 29046446
[TBL] [Abstract][Full Text] [Related]
9. Lentiviral Vector Promoter is Decisive for Aberrant Transcript Formation.
Scholz SJ; Fronza R; Bartholomä CC; Cesana D; Montini E; von Kalle C; Gil-Farina I; Schmidt M
Hum Gene Ther; 2017 Oct; 28(10):875-885. PubMed ID: 28825370
[TBL] [Abstract][Full Text] [Related]
10. Superior lentiviral vectors designed for BSL-0 environment abolish vector mobilization.
Hu P; Bi Y; Ma H; Suwanmanee T; Zeithaml B; Fry NJ; Kohn DB; Kafri T
Gene Ther; 2018 Oct; 25(7):454-472. PubMed ID: 30190607
[TBL] [Abstract][Full Text] [Related]
11. A murine leukemia virus (MuLV) long terminal repeat derived from rhesus macaques in the context of a lentivirus vector and MuLV gag sequence results in high-level gene expression in human T lymphocytes.
Kung SK; An DS; Chen IS
J Virol; 2000 Apr; 74(8):3668-81. PubMed ID: 10729143
[TBL] [Abstract][Full Text] [Related]
12. Drastic decrease of transcription activity due to hypermutated long terminal repeat (LTR) region in different HIV-1 subtypes and recombinants.
de Arellano ER; Alcamí J; López M; Soriano V; Holguín A
Antiviral Res; 2010 Nov; 88(2):152-9. PubMed ID: 20713090
[TBL] [Abstract][Full Text] [Related]
13. Lentiviral vectors for enhanced gene expression in human hematopoietic cells.
Ramezani A; Hawley TS; Hawley RG
Mol Ther; 2000 Nov; 2(5):458-69. PubMed ID: 11082319
[TBL] [Abstract][Full Text] [Related]
14. Comparison of 5' and 3' long terminal repeat promoter function in human immunodeficiency virus.
Klaver B; Berkhout B
J Virol; 1994 Jun; 68(6):3830-40. PubMed ID: 8189520
[TBL] [Abstract][Full Text] [Related]
15. Towards developing HIV-2 lentivirus-based retroviral vectors for gene therapy: dual gene expression in the context of HIV-2 LTR and Tat.
Sadaie MR; Zamani M; Whang S; Sistron N; Arya SK
J Med Virol; 1998 Feb; 54(2):118-28. PubMed ID: 9496370
[TBL] [Abstract][Full Text] [Related]
16. Optimized lentiviral vector design improves titer and transgene expression of vectors containing the chicken beta-globin locus HS4 insulator element.
Hanawa H; Yamamoto M; Zhao H; Shimada T; Persons DA
Mol Ther; 2009 Apr; 17(4):667-74. PubMed ID: 19223867
[TBL] [Abstract][Full Text] [Related]
17. Aberrant Clonal Hematopoiesis following Lentiviral Vector Transduction of HSPCs in a Rhesus Macaque.
Espinoza DA; Fan X; Yang D; Cordes SF; Truitt LL; Calvo KR; Yabe IM; Demirci S; Hope KJ; Hong SG; Krouse A; Metzger M; Bonifacino A; Lu R; Uchida N; Tisdale JF; Wu X; DeRavin SS; Malech HL; Donahue RE; Wu C; Dunbar CE
Mol Ther; 2019 Jun; 27(6):1074-1086. PubMed ID: 31023523
[TBL] [Abstract][Full Text] [Related]
18. Inhibition of HIV-1 infection by lentiviral vectors expressing Pol III-promoted anti-HIV RNAs.
Li MJ; Bauer G; Michienzi A; Yee JK; Lee NS; Kim J; Li S; Castanotto D; Zaia J; Rossi JJ
Mol Ther; 2003 Aug; 8(2):196-206. PubMed ID: 12907142
[TBL] [Abstract][Full Text] [Related]
19. Biosafety challenges for use of lentiviral vectors in gene therapy.
Rothe M; Modlich U; Schambach A
Curr Gene Ther; 2013 Dec; 13(6):453-68. PubMed ID: 24195603
[TBL] [Abstract][Full Text] [Related]
20. Development of a self-inactivating lentivirus vector.
Miyoshi H; Blömer U; Takahashi M; Gage FH; Verma IM
J Virol; 1998 Oct; 72(10):8150-7. PubMed ID: 9733856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
